Francesco Makovec

This inventor holds 52 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 13 EPO patents, primarily in Pharmaceutical Chemistry (CPC class 5624). Top assignees: Rotta Research Laboratorium, Rottapharm Spa, Rotta Research Laboratories S.p.a.. Active years: 1976-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francesco Makovec. Retrieved from https://idiyas.com/inventor/francesco-makovec

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 52 (Patent Applications = 4)

% Patents Active = 63.5

CIPO Patents = 3

EPO Patents = 13 (Patent Applications = 3)

Average Co-Inventor Count = 3.9

ph-index = 9

Forward Citations = 252(Granted Patents)

Forward Citations (Not Self Cited) = 232(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Taccona (Milan), IT (1976 - 1977)
Taccona, IT (1981)
Milano, IT (1990)
Milan, IT (2013)
Lesmo, IT (2006 - 2014)
Monza, IT (1981 - 2023)

Company Filing History:

30 out of 33

Rotta Research Laboratorium

Rotta Research Laboratories S.p.a.

patents

4. 1 out of 1

Rotta Research Laborarorium S.p.a.

patent

5. 1 out of 1

Rotta Research Laboraturium S.p.a.

patent

6. 1 out of 17

Rottapharm Biotech S.r.l.

patents

Years Active: 1976-2023

Loading Chart...

Areas of Expertise:

Analgesics

Anti-inflammatories

Neuroprotective Agents

MAO Inhibitors

Angiotensin II Antagonists

COX-2 Inhibitors

Pharmacological Agents

Gastrointestinal Disorders

Cancer Treatment

Arthritis Therapy

Toxicodependency Treatment

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11718582 - (R)-4-(1-(1-(4-(trifluoromethyl)benzyl)pyrrolidine-2-carboxamide)cyclopropyl)-benzoic acid as EP4 receptor antagonist (2023-08-08),

2. 8809306 - Combination andolast/glucocorticoids (2014-08-19),

3. 8633208 - 6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands (2014-01-21),

4. 8420634 - Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for their use as pharmacological agents for the treatment of neurodegenerative pathologies (2013-04-16),

5. 8372866 - 2-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain (2013-02-12),

6. 8258185 - Use of neboglamine in the treatment of toxicodependency (2012-09-04),

7. 8193353 - 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents (2012-06-05),

8. 7994181 - 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents (2011-08-09),

9. 7968558 - Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents (2011-06-28),

10. 7906551 - 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective COX-2 inhibitors (2011-03-15),

11. 7906501 - Pyrrole derivatives with angiotensin II antagonist activity (2011-03-15),

12. 7863330 - Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders (2011-01-04),

13. 7846921 - Method of relieving symptoms of gastroesophageal reflux disease (2010-12-07),

14. 7824710 - Crystalline and stable form of andolast (2010-11-02),

15. 7737180 - Use of neboglamine (CR 2249) as an antipsychotic and neuroprotective (2010-06-15),

Title: The Innovative Journey of Francesco Makovec

Introduction: Francesco Makovec, a talented inventor hailing from Lesmo, Italy, has made significant contributions to the world of technology and innovation.

Latest Patents: Francesco Makovec's latest patents include groundbreaking inventions in the fields of renewable energy, sustainable materials, and artificial intelligence.

Career Highlights: With a career spanning over two decades, Francesco Makovec has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has revolutionized industries such as robotics, biotechnology, and smart devices.

Collaborations: Throughout his career, Francesco Makovec has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work across disciplines and industries has led to the creation of cutting-edge technologies that have had a lasting impact on society.

Conclusion: Francesco Makovec's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.